5-Iodo-cytidine
5-Iodo-cytidine (5-Iodo-D-cytidine) is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Product Specifications
CAS Number
[1147-23-5]
Product Name Alternative
5-Iodo-D-cytidine
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Nucleoside Antimetabolite/Analog
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/5-iodo-cytidine.html
Concentration
10mM
Purity
99.76
Solubility
DMSO : ≥ 100 mg/mL
Smiles
O=C(N=C(N)C(I)=C1)N1[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O
Molecular Formula
C9H12IN3O5
Molecular Weight
369.11
Precautions
H302, H315, H319, H335
References & Citations
[1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18 (23) :3373-88.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Browse additional items from our catalog
SPATA2L, ID (SPATA2L, C16orf76, Spermatogenesis-associated protein 2-like protein) (MaxLight 750) discontinued
ERGIC1 (NM_020462) Human Tagged ORF Clone Lentiviral Particle
PPP6C, NT (Serine/Threonine Protein Phosphatase 6 Catalytic Subunit, PP6) (MaxLight 650)